Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

29 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
ADME/PK as part of a rational approach to drug discovery.
Eddershaw PJ, Beresford AP, Bayliss MK. Eddershaw PJ, et al. Among authors: bayliss mk. Drug Discov Today. 2000 Sep;5(9):409-414. doi: 10.1016/s1359-6446(00)01540-3. Drug Discov Today. 2000. PMID: 10931658
The effects of hypoxia on drug-metabolizing enzymes.
Woodrooffe AJ, Bayliss MK, Park GR. Woodrooffe AJ, et al. Among authors: bayliss mk. Drug Metab Rev. 1995;27(3):471-95. doi: 10.3109/03602539508998332. Drug Metab Rev. 1995. PMID: 8521751 Review. No abstract available.
Scaling factors for the extrapolation of in vivo metabolic drug clearance from in vitro data: reaching a consensus on values of human microsomal protein and hepatocellularity per gram of liver.
Barter ZE, Bayliss MK, Beaune PH, Boobis AR, Carlile DJ, Edwards RJ, Houston JB, Lake BG, Lipscomb JC, Pelkonen OR, Tucker GT, Rostami-Hodjegan A. Barter ZE, et al. Among authors: bayliss mk. Curr Drug Metab. 2007 Jan;8(1):33-45. doi: 10.2174/138920007779315053. Curr Drug Metab. 2007. PMID: 17266522 Review.
Isolation and culture of human hepatocytes.
Bayliss M, Somers G. Bayliss M, et al. Methods Mol Med. 2005;107:249-67. doi: 10.1385/1-59259-861-7:249. Methods Mol Med. 2005. PMID: 15492377 No abstract available.
29 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page